{"id":"W2090441507","doi":"10.1007/s40265-013-0176-2","title":"T-Cell Trafficking and Anti-Adhesion Strategies in Inflammatory Bowel Disease: Current and Future Prospects","year":2014,"lang":"en","type":"review","venue":"Drugs","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; U.S. Department of Veterans Affairs","keywords":"Vedolizumab; Natalizumab; Medicine; Inflammatory bowel disease; Crohn's disease; Immunology; Leukocyte Trafficking; Disease; Inflammatory Bowel Diseases; Efalizumab; Inflammation; Chemokine; Tumor necrosis factor alpha; Pathology; Infliximab; Multiple sclerosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002334461,0.000497442,0.0005715806,0.0001242415,0.00008124318,0.0001348248,0.0001865933,0.0003123716,0.000004459822],"category_scores_gemma":[0.00001783279,0.0004411803,0.0001693562,0.00005912997,0.0001168232,0.00001221355,0.0001799656,0.0002920793,0.000008297903],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002667174,"about_ca_system_score_gemma":0.0004305709,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":7.648821e-7,"about_ca_topic_score_gemma":0.000004252062,"domain_scores_codex":[0.9981863,0.0001803344,0.0004320026,0.0007009188,0.000168295,0.000332187],"domain_scores_gemma":[0.9990401,0.00001421173,0.0002389855,0.0004251895,0.00003534457,0.0002462244],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001213714,0.000243502,0.003708764,0.1411471,0.00009808889,0.0003630213,0.0004089095,0.00001189941,0.0001390051,0.001304861,0.001674928,0.8507786],"study_design_scores_gemma":[0.0004948819,0.00002055492,0.005903623,0.003060324,0.0001891371,0.000006642887,0.00008463672,0.00001405682,0.000007816155,0.00002777181,0.9895661,0.0006244313],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.07504653,0.9237143,0.000002561341,0.000009011189,0.0002479276,0.0007262315,0.00003972088,0.00002346677,0.0001902473],"genre_scores_gemma":[0.01394529,0.9846696,0.00001664391,0.00001702004,0.0008490785,0.00009718612,0.0002973351,0.00006875612,0.00003905298],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9878912,"threshold_uncertainty_score":0.999804,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007414992976670643,"score_gpt":0.2625337820293175,"score_spread":0.2551187890526469,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}